General Pain

Latest

Large Proportion of COVID-19 Studies Have Low-Level Evidence

A large proportion of studies on COVID-19 have a low level of evidence.

Prenatal Cannabis Exposure Tied to Childhood Sleep Problems

Prenatal cannabis exposure is associated with child sleep outcomes.

The Neurological Symptoms of COVID-19: Practitioner Views

By

Nicola Davies, PhD

Research has revealed that the SARS-CoV-2 viral infection may have neurological manifestations, with critical implications for clinical practice.

A Case of Unremitting Back Pain Following Kidney Stones

By

Shannon E. Whitten, MS, NP-C, APRN-BC

Right-sided flank pain has been present for several months and occurs when standing, bending, and lifting—pain only improves when laying down.

Higher Rates of Pain Found With Essure Birth Control Device

The permanent birth control device Essure is associated with higher rates of chronic lower abdominal or pelvic pain and abnormal uterine bleeding.

Study to Assess Antiviral Antibody Cocktail for COVID-19 Prevention Begins

By

Diana Ernst, RPh

A phase 3 trial evaluating an investigational antiviral antibody cocktail, REGN-COV2, for the prevention of COVID-19 has been initiated by Regeneron Pharmaceuticals.

Chronic Fatigue Syndrome, Viruses, and the Innate Immune System

By

Theodore Henderson, MD, PhD

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a disorder characterized by marked fatigue, exertion induced malaise, cognitive clouding (or brain fog), impaired academic/work performance, disrupted sleep, and joint/muscle pain.

Psychiatric Comorbidities May Raise Risk for Sedative Use in Opioid Use Disorder

By

Emily Pond

Over half of the sample attained opioids through their own prescription, and 47.2% of patients with co-occurring sedative use disorder attained sedatives by prescription.

Perceptions Related to Cannabis-Related Therapies Among Clinicians

By

Madeline Morr

Healthcare professionals see the benefits of prescribing cannabis therapies but report significant knowledge gaps in both recreational and medical cannabis.

Supplements With Undeclared Active Ingredients Pose Substantial Health Risk

By

Cassandra Pardini, PharmD

A recent Morbidity and Mortality Weekly Report highlights the risks associated with use of OTC products containing undeclared prescription ingredients as well as the importance of collaboration between various health departments and systems to ensure a prompt response to an outbreak.